echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > "Hypertension" Which antihypertensive drug is safer?

    "Hypertension" Which antihypertensive drug is safer?

    • Last Update: 2021-07-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Hypertension guidelines in the United States and Europe list 30 drugs in 5 different drug classes as possible options, but there are few face-to-face studies to help doctors determine which drug is better


    People who are just starting to treat high blood pressure can also benefit from two different drugs-angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs)-according to a report published today in American Heart According to the analysis of real-world data in the Association’s Journal of Hypertension, ARBs have fewer drug side effects


    Although antihypertensive drugs called angiotensin converting enzyme (ACE) inhibitors may be more common, angiotensin receptor blockers (ARBs) are equally effective and may have fewer side effects


    This finding is based on an analysis of eight electronic health records and insurance claims databases in the United States, Germany, and South Korea, which included nearly 3 million patients who had taken hypertension medication for the first time and had no history of heart disease or stroke


    Both of these drugs act on the renin-angiotensin-aldosterone system, which is a group of related hormones that work together to regulate blood pressure


    "In professional guidelines, several types of drugs are also recommended as first-line treatment


    The AHA/ACC 2017 "Guidelines for the Prevention, Detection, Evaluation and Management of Hypertension in Adults" stated that the main drugs for the treatment of hypertension are thiazide diuretics, ACE inhibitors, ARBs and calcium channel blockers because they have been proven Can reduce cardiovascular events


    This study reviewed the health records of patients who used a single drug for antihypertensive therapy for the first time between 1996 and 2018


    They found no significant differences in the incidence of heart attacks, strokes, heart failure hospitalizations, or any cardiac events


    The risk of fluid accumulation and deep swelling of the skin and mucous membranes (angioedema) may be 3.


    32% of people are more likely to cough (may be dry cough, persistent cough);

    The possibility of sudden pancreatitis (pancreatitis) is 32% higher;

    The possibility of gastrointestinal bleeding increased by 18%


    Narrow selection

    Data from electronic health records and insurance claims is challenging to use in research


    Using this method, the researchers tracked four cardiovascular outcomes—heart attack, heart failure, stroke, and sudden cardiac death—and 51 adverse events after patients started antihypertensive therapy


    Researchers found that the vast majority of patients (2.


    Our research largely confirms that these two antihypertensive drugs have similar effects, although ARBs may be a little safer than ACE inhibitors


    # # #


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.